On October 20, 2011, the Food and Drug Administration posted revised versions of the following Import Alerts on the detention without physical examination of:
On October 19, 2011, the Food and Drug Administration posted revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration has issued a 2012-2016 Strategic Plan for its Foods and Veterinary Medicine Program. FDA's goals include improving assurance that imported foods and feeds meet preventive control standards; effectively implementing new and existing enforcement tools; updating the Nutrition Facts label; reducing sodium content and industrially produced trans fat in the food supply; improving the safety of dietary supplement products and the supply chain; setting preventive control standards for produce safety and for safe food transport; applying public health metrics and goals for risk-based food safety priority setting; etc.
On October 18, 2011, the Food and Drug Administration posted revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration has issued a final rule amending its bottled water quality standard regulations to establish an allowable level for the chemical di(2-ethylhexyl)phthalate (DEHP). As a consequence, bottled water manufacturers are required to monitor (i) their finished bottled water products for DEHP at least once each year under the current good manufacturing practice (CGMP) regulations and (ii) their source water for DEHP as often as necessary, but at least once every year (unless certain exemption criteria are met). FDA states this will ensure that its water bottle quality standards will be no less protective of the public health than those set by the Environmental Protection Agency for public drinking water.
On October 17, 2011, the Food and Drug Administration issued a public letter to corporate CEOs regarding baby products that claim to prevent or reduce the risk of sudden infant death syndrome (SIDS). In addition, on October 18, the American Academy of Pediatrics expanded its guidelines for infant sleep safety and SIDS risk reduction. Both the FDA and AAP state that soft objects should not be in the crib, including pillows, blankets, or bumper pads. FDA also stated that infant sleep positioners should not be used in cribs.
On October 17, 2011, the Food and Drug Administration posted revised versions of the following Import Alerts on the detention without physical examination of:
In response to requests, the Food and Drug Administration is extending the comment period until November 30, 2011 (from October 17) regarding its recent request for comments on the burden to small businesses of the Food Safety Modernization Act fee amounts of $224/$325 per hour for certain FDA activities. FDA is interested in obtaining comments to help in its preparation of a proposed set of guidelines on the burden of fee amounts on small business.
On October 14, 2011, the Food and Drug Administration posted revised versions of the following Import Alerts on the detention without physical examination of:
The American Chemistry Council has petitioned the Food and Drug Administration to withdraw approval for use of polycarbonate resins, containing bisphenol A1 (BPA) in baby bottles and children’s sippy cups.